Advances in influenza treatment

Journal of Infection and Chemotherapy

Volumn 7, Issue 4, 2001, Pages 199-204

  Kashiwagi, S ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

Author keywords

Amantadine; Influenza; Nueraminidase inhibitor; Oseltamivir; Zanamivir

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; INFLUENZA; JAPAN; REVIEW;

EID: 0035703064     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101560170014     Document Type: Review

References (13)

1. Antiviral activity of 1-adamantanaminc (amantadine)
2. Recommendations of the Advisory Committee on Immunization Practice: Prevention and control of influenza
3. 4-Guanidino-2, 4-dideoxy-2, 3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro
4. Randomized trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections
5. Effect of zanamivir on duration and resolution of influenza symptoms
6. Impact of zanamivir on antibiotc use for respiratory events following acute influenza in adolescents and adults
7. Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma or chronic obstructive pulmonary diseases. A double-blind, randomised, placebo-controlled, multicentre study
8. Zanamivir, a new targeted therapy in the treatment of influenza: A patient perspective assessed by questionaire
9. Zanamivir in the prevention of influenza among healthy adults: A randomized controlled trial
10. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial
11. Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza - Placebo-controlled double-blind multicenter phase III trial
12. Use of the selective oral neuraminidase inhibitor Oseltamivir to prevent influenza
13. Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza - Placebo-controlled double-blind multicenter phase III trial